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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of morbidity and mortality in both hospitals and
the community. Traditionally, MRSA was mainly hospital-associated (HA-MRSA), but in the past decade community-
associated strains (CA-MRSA) have spread widely. CA-MRSA strains seem to have significantly lower biological costs of
resistance, and hence it has been speculated that they may replace HA-MRSA strains in the hospital. Such a replacement
could potentially have major consequences for public health, as there are differences in the resistance spectra of the two
strains as well as possible differences in their clinical effects. Here we assess the impact of competition between HA- and CA-
MRSA using epidemiological models which integrate realistic data on drug-usage frequencies, resistance profiles, contact,
and age structures. By explicitly accounting for the differing antibiotic usage frequencies in the hospital and the community,
we find that coexistence between the strains is a possible outcome, as selection favors CA-MRSA in the community, because
of its lower cost of resistance, while it favors HA-MRSA in the hospital, because of its broader resistance spectrum.
Incorporating realistic degrees of age- and treatment-structure into the model significantly increases the parameter ranges
over which coexistence is possible. Thus, our results indicate that the large heterogeneities existing in human populations
make coexistence between hospital- and community-associated strains of MRSA a likely outcome.
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Introduction
Over the past ten years community-associated strains of
methicillin-resistant Staphylococcus aureus (CA-MRSA) have emerged
and spread rapidly, accounting for large increases in disease both
in the community and in the hospital [1,2]. While originally
thought to be primarily a hospital-associated pathogen (HA-
MRSA), the emergence of a community-associated strain, which
has a different genetic background [2] and drug susceptibility
profile [3,4], has raised questions about how the epidemiology and
the ecology of the disease will evolve, particularly with respect to
which strain will predominate.
MRSA resistance is mediated by the integration of a
staphylococcal cassette chromosome mec (SCCmec) in a site-
specific manner into the staphylococcal genome [5]. Eight
different SCCmec allotypes, as well as numerous subtypes,
which encode varying levels of resistance to multiple
antibiotics, have been described to date [2]. In vitro growth
assays have demonstrated an inverse correlation between
resistance level and growth rate [6,7], which presumably
limits the spread of HA-MRSA strains – characterized by high
levels of resistance to multiple antibiotics –beyond hospitals
[8,9]. On the other hand, the maintenance of resistance in the
most common community-associated strains, which are
characterized by resistance to only a limited set of antibiotics,
seems to cause only a negligible reduction in the growth rate
relative to non-resistant strains [10,11]. This in turn accounts
for its wide dissemination in the community and the
assumption that it is more easily transmitted than HA-MRSA
strains [2].
Given the presumed relatively lower cost of resistance in
CA-MRSA, it has been speculated that CA-MRSA strains
may eventually replace HA-MRSA strains in the hospital
[12,13]. However, the high costs of resistance for HA-MRSA
strains might be offset by the fact that they are resistant to a
much broader range of antibiotics than CA-MRSA strains
[3,4]. If this were the case, coexistence between the two strains
might be a plausible long-term scenario. In fact, a recent
empirical study [14] indicates that despite a substantial
increase in patients infected with CA-MRSA strains, the
frequency of HA-MRSA strains in the hospital has remained
remarkably stable.
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Intuitively, both outcomes, coexistence and replacement, are
possible. On the one hand, replacement, or competitive
exclusion, is the standard outcome expected by ecological
theory for two strains occupying the same ecological niche.
Accordingly, explaining observed coexistence in other bacte-
rial pathogens has proven challenging [15,16]. On the other
hand, structural differences in hospital and community
populations may impose sufficiently different selective advan-
tages to allow coexistence. Thus, HA-MRSA with its broad
resistance spectrum may be better adapted to the hospital
environment where antibiotic use is common, whereas CA-
MRSA may be better adapted to the community, where
antibiotic use is less frequent and hence a broad resistance
spectrum cannot compensate for the reduced transmissibility of
HA-MRSA. One factor, which may counteract this mecha-
nism, is that the average length of stay of a patient in the
hospital (4–5 days) is much shorter than the time until a patient
colonized with MRSA clears the bacteria (several 100 days
[17]). Accordingly, a given colonization (bacterial population
within a host) almost never experiences only the hospital
environment, hence making local adaptation difficult. It
follows from the above reasoning that addressing the question
of coexistence is not possible from the hospital perspective
alone, but instead it is necessary to take both hospital and
community populations (and their frequent exchange) into
account.
While this question of coexistence is an interesting ecological
problem, it is also an important question for public health as
the outcome of the interaction between CA-MRSA and HA-
MRSA may have epidemiological and clinical consequences:
HA-MRSA has a much broader resistance spectrum than CA-
MRSA [18] and may therefore be more difficult to treat.
Moreover, the two strains also differ with respect to their
pathogenicity. While CA-MRSA has primarily been associated
with skin- and soft-tissue infections, there have also been
suggestions that it may be more invasive and virulent than HA-
MRSA [2]. If CA-MRSA completely replaces HA-MRSA,
hospitals might be confronted with a more virulent but also
more treatable pathogen. Moreover, their ability to replicate
and transmit in the community may mean significantly more
infections as well. In this analysis, we use epidemiological
models which integrate realistic data on drug-usage frequen-
cies, resistance profiles, contact, and age structures to assess
the impact of competition between HA- and CA-MRSA
strains. In particular, we examine the likelihood of coexistence
as an outcome.
Methods
Models
We considered three epidemiological models of increasing
complexity and assessed how the interaction between hospital
and community populations could lead to stable coexistence
between HA- and CA-MRSA. The basic model assumes that
all individuals, regardless of age, have similar hospital
admission and discharge rates as well as antibiotic usage rates.
In this case the only difference between the hospital and the
community is the usage frequency of antibiotics, which may
lead to selection favoring one strain in the community and the
other in the hospital. Next we considered two extensions of this
model. First we examined how heterogeneity between age-
classes with respect to hospitalization rates and antibiotic usage
impacted coexistence between strains in each setting. Second,
we explicitly distinguished between treated and untreated
patients, thereby capturing the prophylactic effect of treat-
ment, which is likely to be much stronger in the hospital than
in the community.
The epidemiological dynamics of CA- and HA-MRSA were
described by set of ordinary differential equations. Based on
estimates from the literature and an analysis of public-use
data in the United States, we assume differing dynamics of
colonization, infection, and antibiotic use between the
hospital and the community and consider how differing
implementations of the host population structure impacts
the dynamics of each strain and examine the parameter
ranges over which coexistence occurs. In each of these
models, the possibility of coexistence between HA- and CA-
MRSA for a given parameter-combination was determined by
an invasibility analysis: First, the system is allowed to reach
the equilibrium with one strain only (burn-in time: 56104
days); then the other strain is introduced at low abundance; if
the introduced strain increases in frequency after the
introduction, we say that it can invade the equilibrium
determined by the resident strain. If both strains (HA-MRSA
and CA-MRSA) can invade the equilibrium of the other
strain, this indicates coexistence.
Basic model
In the basic model we assume that populations in the
hospital and community are homogenous. The two popula-
tions are connected through admission into the hospital
population (with rate a) and discharge into the community
with rate (d) and are each subdivided into individuals that are
uncolonized (SC and SH), colonized with CA-MRSA (CC,CA and
CH,CA), and colonized with HA-MRSA (CC,CA and CH,CA). In
the community, colonized individuals infect uncolonized
individuals with a transmission rate bC,CA for CA-MRSA and
Author Summary
One of the most notorious cases of antibiotic-resistant
bacteria is methicillin-resistant Staphylococcus aureus
(MRSA), which causes diseases ranging from skin and soft-
tissue infections to pneumonia and septicemia. Tradition-
ally, MRSA was mainly hospital-associated, but in the past
decade community-associated strains have spread widely.
Typically drug-resistant bacteria have lower reproduction or
transmission rates, called a fitness cost. Because this cost is
estimated to be significantly lower for community-associ-
ated strains, it has been predicted that these will eventually
replace the hospital-associated strains. However, hospital-
associated strains are resistant against a greater variety of
antibiotics, which may compensate for the higher fitness
cost. Here, we integrate realistic data on drug-usage,
resistance profiles, contact, and age structures into a
mathematical model of MRSA transmission to predict the
competition between hospital- and community-associated
strains. We find that for a realistic degree of population
structure it is likely that both strains of MRSA will coexist in
the long term. This results from significantly different
hospitalization and antibiotic consumption rates between
age groups. In particular, elderly individuals have much
higher rates of antibiotic usage and hospitalizations than
other age groups. This generates a situation where
community-associated strains can predominate in the
community but are outcompeted in the hospital, resulting
in coexistence in the population.
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bC,HA for HA-MRSA. In the hospital the corresponding rates
are bH,CA and bH,HA. We assume that regardless of location, in
the absence of treatment HA-MRSA suffers a fitness cost (s)
against CA-MRSA, which is assumed to be due to a reduced
transmission rate; i.e. bX,HA = bX,CA(1-s). Colonization can be
cleared either spontaneously, with rate cBL, or through
treatment. Since colonization is significantly more common
than infection, we assume that antibiotic use is independent of
the colonization status of the patient. Antibiotic use occurs at
rate tC and tH in the hospital and community, respectively. As
treatment is in most cases not specific for S. aureus, we assume
that the probability (fC,X and fH,X) that a given course of
treatment is effective against either strain corresponds to the
proportion of drugs to which each is susceptible among all
prescribed drugs (see parameters section). We further assume
that even if the drug consumed is effective, there are reasons
other than antibiotic resistance that a bacterial colonization
may not be cleared, i.e. effectively treated patients clear the
bacterial population only with a probability cT,1. The basic
model is described by the following set of ordinary differential
equations:
Age-structured model
The age-structured model is derived from the basic model by
sub-dividing each compartment into 18 different age classes (five-
year bins for the ages from 0 to 85 and one bin for 85+). For
instance, the compartment SC (uninfected individuals in the
community) is subdivided into the compartments SC
1, SC
2…
SC
18, where SC
1 covers susceptible individuals of age 0–5, SC
2 of 5–
10, etc. Admission rates, aj, and discharge, dj, rates are assumed to
depend on the age class j (see parameters section). The impact of
age structure on contact rates is captured by assuming that the
transmission rates in the community, bC,X
j,k, are proportional to
the frequency of physical contacts (divided by the number of
people in that age class). Because detailed contact data from the
US were not available, we used data on contact rates measured in
the UK [19]. Finally, the treatment rate tC
j in the community also
varies with age class j. Similar data on the age-dependency of
contact rates and treatment rates in the hospital were not available
to our knowledge. Because contact rates are likely to be more
uniform in the hospital, since most of transmission is indirect, we
made the conservative assumption that contact and treatment
rates in the hospital are uniform regardless of age. The age-
structured model is described by the following set of ordinary
differential equations:
dSC
dt
~{SC bC, CACC, CAzbC, HACC, HA
 
zCC, CA cBLztCfC, CA cT
 
z
CC, HA cBLztCfC, HA cT
 
{aSCzd SH
dCC, CA
dt
~SCbC, CACC, CA{CC, CA cBLztCfC, CA cT
 
{aCC, CAzd CH, CA
dCC, HA
dt
~SCbC, HACC, HA{CC, HA cBLztCfC, HA cT
 
{aCC, HAzd CH, HA
dSH
dt
~{SH bH, CACH, CAzbH, HACH, HA
 
zCH, CA cBLztHfH, CA cT
 
z
CH, HA cBLztHfH, HA cT
 
zaSC{d SH
dCH, CA
dt
~SHbH, CACH, CA{CH, CA cBLztHfH, CA cT
 
zaCC, CA{d CH, CA
dCH, HA
dt
~SHbH, HACH, HA{CH, HA cBLztHfH, HA cT
 
zaCC, HA{d CH, HA
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A diagram of the age-structured model is found in Figure 1.
Treatment-structured model
The treatment-structured model (Equation S1 in the online
supplementary material) is derived from the basic model by
subdividing each compartment according to treatment status.
Specifically, we distinguish between four treatment classes: 1)
Untreated (U); 2) treated with a drug that is effective against
neither CA-MRSA nor HA-MRSA (treatment T(1)); 3) treated
with a drug that is effective against CA-MRSA but not HA-MRSA
(treatment T(2)); and 4) treated with a drug that is effective against
both CA-MRSA and HA-MRSA (treatment T(3)). Treatment with
a drug from class j is initiated at rate tC
j and tH
j. Upon treatment
initiation with an effective drug, the infection is either cleared
immediately with a probability cT or alternatively remains
colonized (this is an approximation to the real dynamics in which
the patient would clear after a given amount of time). Finally,
treated individuals stop treatment at a rate r (i.e. the inverse
duration of antibiotic use). A diagram of the model is found in
Figure S1.
The treatment-and-age-structured model is derived from the
treatment-structured model in the same way the age-structured
model is derived from the basic model.
Parameters
Our models integrate realistic values for drug-usage frequencies,
resistance profiles, age structure, age-dependent contact patterns,
and hospitalization rates. Usage frequencies, age distribution,
hospitalization rates, and the mean length of stay in the hospital
were estimated from publicly available data by five-year age
groups. Figure 2 summarizes the age-dependency of population
size, hospitalization rates, length of stay in the hospital, and
antibiotic usage rates in the community. As data on the age-
dependency of treatment and contact rates are available for the
community only, we make the conservative assumption that these
rates are homogenous in the hospital (see discussion). In contrast to
these parameters there is large uncertainty concerning the
magnitude of transmission rates (particularly in the hospital) and
especially concerning the degree to which the transmission rate of
HA-MRSA is reduced compared to that of CA-MRSA (i.e. the
selective cost of HA-MRSA). Therefore we vary these parameters
over broad ranges. A summary of the parameter values and ranges
can be found in Table 1.
The number of hospitalizations and average length of stay for
each age group was estimated from the Nationwide Inpatient
Sample (NIS), Healthcare Cost and Utilization Project, Agency
for Healthcare Research and Quality for the year 2008. The NIS
contains data on ,8 million records of hospital stays annually
from about 1,000 hospitals, approximating a 20% stratified
sample of US community hospitals, and includes all nonfederal,
short-term, general, and specialty hospitals, such as obstetrics-
gynecology, ear-nose-throat, orthopedic, and pediatric institu-
tions. The NIS includes public hospitals and academic medical
centers but excludes long- and short-term acute rehabilitation
facilities, psychiatric hospitals, and alcoholism and chemical
dependency treatment facilities. Hospitalization rates were
calculated as the average number of hospitalizations per-person
per-day by age group. The numbers of individuals for each age
group were obtained from the US Census bureau’s annual
estimates of the resident population by five-year age groups
(www.census.gov).
Antibiotic usage in the community was estimated based on data
from the National Ambulatory Medical Care Survey (NAMCS)
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and the National Hospital Ambulatory Medical Care Survey
(NHAMCS) for 2008. NAMCS is an annual national survey of
visits to non-federally employed office-based physicians who are
primarily engaged in direct patient care, and NHAMCS is
designed to collect data on the utilization and provision of
ambulatory care services in hospital emergency and outpatient
departments and in ambulatory surgery centers. Weighted patient
level data was used to estimate the annual number of prescriptions
for antibiotics that were written for each age group. The usage rate
was calculated as the average number of prescriptions written per
person per day per age group. Antibiotic usage in the hospital was
estimated based on the data from [20], which reported antibiotic
use from 130 US hospitals (see Table 1).
To calculate the approximate effectiveness of community
antibiotic usage on CA- and HA-MRSA, we calculated the
number of prescriptions for each antibiotic class and, based on
assumptions about the effectiveness of each antibiotic against
CA- and HA-MRSA, we estimated the percentage of drug
usage that was effective against each pathogen (Supplementary
Table S1). The effectiveness of drugs used in the hospital is
similar to the community though skewed towards some of the
more effective drugs [20,21]. Thus, we assume that the
effectiveness of antibiotic usage on CA- and HA-MRSA is
slightly more effective in the hospital than in the community
(see Table 1).
Results
In order to explore the possibility of coexistence between HA-
MRSA and CA-MRSA, we consider a series of epidemiological
models of increasing complexity. The simplest, basic model
ignores all population structure beyond the distinction between
hospital and community. We then extend this basic model by
incorporating age- and treatment-heterogeneities in accordance
with published data (see Methods).
For the basic model, which ignores both age- and treatment-
structure, we find that the interaction between the hospital and the
community can in principle generate coexistence between HA-
and CA-MRSA. However, we observed this outcome only for a
relatively narrow band of fitness-costs for HA-MRSA (Figure 3).
Moreover, the width of this band decreases with decreasing
transmissibility in the hospital, which we quantified as the average
Figure 1. Flow diagram of the age structured model. Susceptible individuals (S), which are structured into multiple age classes, can be
colonized by CA- or HA-MRSA in the community or in the hospital. Colonized individuals, which are also structured by age, clear the pathogen either
by treatment or through natural immune clearance. Individuals move between the hospital and the community at the same rate regardless of
colonization status.
doi:10.1371/journal.ppat.1003134.g001
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number of secondary cases caused by the admission of one patient
to the hospital containing only susceptible patients (y-axis in
Figure 3). Of note, the parameter range for which coexistence
occurs is much narrower than the parameter range for which HA-
MRSA is fitter than CA-MRSA in the hospital but less fit than
CA-MRSA in the community (see red bars in Figure 3). Thus
opposite directions of selection are not a sufficient condition for
coexistence. This is due to the significant linkage between the two
systems caused by the high-turnover (admission/discharge) in the
hospital, which results in the two strains being cycled into and out
of the community, making it harder for the two strains to coexist.
If the cost of HA-MRSA exceeds the values in the coexistence
range, the equilibrium in which only CA-MRSA is present
becomes stable; if the cost is smaller, the equilibrium in which HA-
MRSA can exclude CA-MRSA becomes stable. Such a narrow
range of coexistence is not unexpected for a homogeneous model.
However, the epidemiology of MRSA exhibits several heteroge-
neities which can stabilize coexistence over a broader range of
conditions.
Heterogeneities increase the range of coexistence
We included age-dependent transmission rates for the commu-
nity by assuming that transmission rates are proportional to the
rate of physical contact [19]. Including age structure in this
manner substantially broadens the parameter range over which
HA- and CA-MRSA can coexist (Figure 4). This increase is due in
part to relative differences in hospitalization between younger and
older individuals, which changes the relative difference in selection
between HA- and CA-MRSA strains. Because the hospital
admission rate and the average length of stay increases as
individuals age, older individuals are more likely to spend time
in the hospital, where MRSA is favored, and consequently they
are more likely to be colonized with HA-MRSA which increases
the range over which HA-MRSA is able to persist despite an influx
of CA-MRSA from the community. Moreover, the number of
physical contacts an older person has in the community is
considerably lower than the corresponding number for young
persons. This in turn further reduces the selective advantage of
CA-MRSA in old age classes. As physical contact occurs
preferentially between members of the same or neighboring age
classes [19], this further contributes to maintaining the association
between age and strain.
An additional source of heterogeneity is treatment itself. We
take this heterogeneity into account by explicitly tracking the
treatment status of patients and assuming that individuals
receiving a given antibiotic cannot be colonized with strains that
are susceptible to this drug. Including treatment heterogeneity in
this way leads to an additional, substantial extension of the
Figure 2. Distribution of the US population over age classes, age dependency of hospitalizations, treatment rates, and durations of
hospitalization in the US. Data are shown for the 18 age classes used in the age-structured model.
doi:10.1371/journal.ppat.1003134.g002
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parameter range over which coexistence occurs (Figure 5). This is
because antibiotic prophylaxis of colonization creates a substantial
additional selective advantage for HA-MRSA (which has the
broader resistance spectrum) in the hospital. However, whereas
the fraction of protected patients is large in the hospital, it is
negligible in the community and hence prophylaxis does not
substantially increase the fitness of HA-MRSA in the community.
Treatment heterogeneity and age-structure act synergistically to
increase coexistence, such that the broadest coexistence range can
be observed for the treatment- and age-structured model (see
Figure 5).
Different costs of resistance in hospital and community
HA-MRSA is most likely adapted to the hospital environment
in other ways than by its broad antibiotic resistance spectrum (e.g.
tolerance to disinfectants, smaller requirements of invasibility, etc.)
[2,22]. Accordingly, it is likely better able to compete against CA-
MRSA (in the absence of therapy) in the hospital as opposed to the
community. Taking this effect into account, we find that as the
fitness-cost of HA-MRSA in the hospital decreases relative to CA-
MRSA, the maximal fitness cost of HA-MRSA for which
coexistence occurs is strongly increased. By contrast the minimal
cost for coexistence changes only weakly, because reducing the
cost of resistance in the hospital does not affect relative fitness in
the community (Figure 6). Thus, context specific fitness costs
further facilitate coexistence between HA- and CA-MRSA. It is
remarkable that decreasing the cost of HA-MRSA in the hospital
has a much stronger effect in the presence of age structure than in
its absence (which indicates that age structure helps separate the
hospital from the community). Thus there is a synergistic effect
between age-structure and hospital specific reduction of fitness
costs.
Simulation of transient strain dynamics
The above analysis was based on the ability of one strain to
invade the equilibrium defined by the presence of the other strain.
This method indicates where the two strains can coexist at
equilibrium and therefore allows one to assess the main ecological
forces underlying coexistence and competitive exclusion. Howev-
er, it has three disadvantages: First, the equilibrium might be
attained only very slowly: for instance two strains might coexist for
a transient period which can extend over decades even though the
equilibrium analysis indicates that one strain should exclude the
other. Second, even if the two strains coexist one of them might
attain only very low levels (i.e. even though the two strains can
coexist in theory, almost all infections are caused by one single
strain). Third, the pairwise-invasibility approach only allows an
analysis of the competitive interaction of two strains, whereas, in
Table 1. Default model parameters of the basic model.
Parameter Explanation Default Value
a Admission rate to hospital 0.00032 d21*
d Discharge rate from hospital 0.25 d21*
tC Treatment rate in community 0.0015d
21**
tH Treatment rate in hospital 0.2 d
21***
fH,HA Probability that a treated HA-MRSA colonized individual
receives effective drugs in the hospital
0.1#
fH,CA Probability that a treated CA-MRSA colonized individual
receives effective drugs in the hospital
0.9#
fC,HA Probability that a treated HA-MRSA colonized individual
receives effective drugs in the community
0.03#
fC,CA Probability that a treated CA-MRSA colonized individual
receives effective drugs in the community
0.7#
cT Probability that patient clears infection given appropriate
treatment
0.5 [43]
cBL Base-line clearance rate 1/300 d
21 [44]
R0
CA,C Basic reproductive ration of CA-MRSA in community 1.4##
RA
HA,H Single-admission basic reproductive number of HA-MRSA
in hospital
Variable (0.5–1.5)###
s Reduction of transmissibility of HA-MRSA (bX,HA =bX,CA(1-s)) Variable (0.1–0.5)
bX,Y Transmission rate of strain x in setting y Determined by R0 and s
*Average transmission and discharge rate in the US (see methods section); for age-class dependent rates see Figure 1.
**Average number of antibiotic prescriptions in the US (data from the data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital
Ambulatory Medical Care Survey (NHAMCS)); see Table S1.
***Polk et al [20] measured antibiotic use in 130 US hospitals. They found that 60% of all discharged patients received at least one dose of an antibacterial drug. With an
average length of stay of 4 days (see *) a daily treatment rate of 0.2 leads to 0.55% of patients receiving treatment during their stay.
#fX,Y was calculated as the fraction of drugs used in setting X that are effective against the strain Y (see methods section).
##The basic reproductive ratio of CA-MRSA in community was determined under the assumption that this strain pays no cost of resistance; i.e. it has the same
transmission rate as methicillin-sensitive S aureus. The latter colonizes about 30% of individuals in the community and with an R0 of 1.4 the expected prevalence is 1-1/
1.4 = 0.29.
###The single-admission basic reproductive number of HA-MRSA in the hospital corresponds to the number of secondary infections caused by a single colonized
individual admitted to a hospital containing only susceptible individuals and is given by the dominant eigenvalue of the next-generation matrix B V21. The matrix B is
given by Bij = bHA,H
ij Si, [with Si the frequency of susceptibles of age-class i in the disease-free equilibrium in the hospital. In the absence of age structure Si = a/d for all i.
In the presence of age structure Si = ai/di *(the proportion of the total population in age group i) (see Figure 2)]. The matrix V is given by Vij = dj+cBL+tH cT fH,HA for i = j
and Vij = 0 for i?j.
doi:10.1371/journal.ppat.1003134.t001
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reality, several S. aureus strains compete with each other: Notably,
HA-MRSA and CA-MRSA compete with methicillin sensitive S.
aureus (MSSA), which could modify their interaction.
In order to address these issues, we considered a more
pragmatic definition of coexistence: We initiated the population
either with HA-MRSA as the only resident strain or with two
resident strains (HA-MRSA and MSSA) and ran the simulation for
30 years. Then we add the new strain (CA-MRSA) and examined
how the frequencies of each changed over time. Specifically, we
tested after 10, 20, 50, 100, and 200 years, which strains still exist
in substantial frequency (using a threshold of 5%). Note that we
focused here only on the invasion of HA-MRSA/MSSA
equilibrium by CA-MRSA rather than the opposite, since the
former describes the current epidemic development (whereas the
latter is merely of theoretical interest).
We first considered the interaction between CA-MRSA and
HA-MRSA (in analogy to the above analyses). We find that the
two strains can coexist during a long transient phase (10–50 years)
for a broad range of conditions, which do not support coexistence
at equilibrium (see Figure 7). Moreover, we can substantially
reduce the range of realistic parameters by considering the
interaction between HA-MRSA and MSSA: as we know that HA-
MRSA has attained substantial frequencies (in the USA at least)
after,50 years of methicillin use, the model is only consistent with
reality for those parameter-combinations for which this is the case.
Figure S2 shows that an invasion of HA-MRSA into the MSSA
equilibrium is only possible if the fitness cost of HA-MRSA is
below a threshold that is dependent upon the average number of
secondary cases caused by the admission of one patient to the
hospital containing only susceptible patients (R0
HA,H). This
threshold is indicated in Figure 7 by the dashed orange line. As
it is also a fact that CA-MRSA was able to invade HA-MRSA, the
realistic parameter range in Figure 7 is delimited by the dark grey
area (corresponding to parameter values where the CA-MRSA
invasion is impossible) to the left and the orange line to the right.
Thus, Figure 7 indicates that we would expect a long-term
coexistence between HA-MRSA and CA-MRSA for most realistic
parameter combinations.
When we consider the interaction between all three strains by
including MSSA as one of the initial resident strains, we find
that the parameter range in which all three strains can coexist
shrinks successively with increasing time (see Figure 8) and
eventually vanishes (results not shown). This is not unexpected,
as the model structure assumes that the hospital and the
community are two different ecological niches, which can thus
maximally support the coexistence of only two strains over the
long-term. However, we do find that all three strains can coexist
for a broad range of conditions during a long transient time-
Figure 3. Parameter range for which HA-MRSA and CA-MRSA coexist. The blue area indicates the parameter-combinations for which HA-
MRSA and CA-MRSA coexist. The dark grey region indicates the parameter-combinations in which HA-MRSA cannot be invaded by CA-MRSA. The
light-grey region indicates parameter-combinations in which CA-MRSA cannot be invaded by HA-MRSA. The range between the two red lines
corresponds to fitness costs for which selection in the hospital and community act in opposite directions (i.e. CA-MRSA is fitter in the community and
HA-MRSA is fitter in the hospital). The x-axis corresponds to the fitness disadvantage of HA-MRSA compared to CA-MRSA in the absence of effective
therapy. The y-axis corresponds to the average number of secondary infections caused by a single colonized individual admitted to a hospital
containing only susceptible individuals (single-admission reproduction number R0
HA,H [41], see Table 1).
doi:10.1371/journal.ppat.1003134.g003
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span of several decades. Overall, these results indicate that
transient effects can strongly extend the range of coexistence,
and even allow for long-term de-facto coexistence where this
would not be expected at equilibrium.
Discussion
We examined how differences in age-structured patterns of
antibiotic use and hospitalization rates can promote coexistence of
CA- and HA-MRSA. Overall, our results show that hospital and
community-associated strains of MRSA can coexist if the broader
resistance spectrum of the hospital-associated strains is balanced
by intermediate fitness-disadvantages in the absence of treatment.
For such intermediate fitness costs, the hospital-associated strains
have higher fitness in the hospital, where treatment rates are high,
whereas community-associated strains have a higher fitness in the
community were treatment rates are low. Despite opposite
directions of selection, both strains are present in both environ-
ments if there is coexistence at all (see Figure S3 for example runs).
This occurs because of the high rates of discharge and
hospitalization, which cycle individuals between the hospital and
the community. Moreover, our results also indicate that opposite
directions of selection are not sufficient for maintaining coexis-
tence. This is especially true for our basic model describing well-
mixed populations in the hospital and community, in which we
found coexistence only for a very narrow range of HA-MRSA
fitness-costs.
Including heterogeneity in the form of realistic age- and
treatment-structures into the model significantly increases the
range of parameters over which coexistence can occur, making it a
likely outcome. Furthermore, the fitness cost of HA-MRSA in the
absence of treatment is presumably weaker in the hospital than in
the community because of factors such as easier invasion due to
open wounds, catheters, etc., as well as increased use of antiseptics
to which the hospital strain might be better adapted. Taking this
possibility into account leads to an additional, substantial increase
in the range over which coexistence is likely. Thus, coexistence
between HA-MRSA and CA-MRSA is a likely outcome due to the
combined effect of hospital-community interactions, age-structure,
treatment-structure, and possibly setting dependent fitness costs in
the absence of treatment.
Coexistence is mainly dependent upon the cost of HA-MRSA
being neither too high nor too low. It should be noted, however,
that the upper bound for resistance costs is, in this context, more
informative than the lower bound. For costs of HA-MRSA below
the lower bound, we would expect that CA-MRSA could not
invade the HA-MRSA equilibrium. However, such an invasion is
exactly what occurred during the 1990s. Thus, we know that
fitness-costs of HA-MRSA are high enough to allow the invasion
of CA-MRSA. The crucial question is whether they are low
enough for this invasion to stop before CA-MRSA has completely
replaced HA-MRSA.
The width of the coexistence range depends strongly on how
effectively MRSA can transmit in the hospital. In our simulations
Figure 4. The blue area indicates the parameter combinations for which HA-MRSA and CA-MRSA coexist in the basic model. The red
area indicates co-existence in the age-structured model. Axes and parameter values are the same as in Figure 3. Note that in order to assure
comparable transmissibility measures as y-axes in the homogeneous and heterogeneous models, we measure transmissibility as the single-admission
reproductive number R0
HA,H – i.e. the dominant eigenvalue of the next-generation matrix of the hospital [41,42] (see Table 1).
doi:10.1371/journal.ppat.1003134.g004
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we quantified this transmissibility as the average number of
secondary cases caused by the admission of one patient to the
hospital containing only susceptible patients (RA). If this value is
considerably smaller than one (i.e. hospitals cannot maintain the
spread of MRSA on their own), then the coexistence range
becomes very narrow. This is because coexistence relies on
opposite directions of selection in the hospital and community
environment. If however, one of these environments does
contribute only very weakly to transmission, this balancing effect
cannot take place. The only published estimate for RA we are
aware of found values of 0.68 (0.47–0.95) and 0.93 (0.71–1.21) for
two Dutch hospitals; one implies a broad and one a narrow
coexistence range (The same study also reported an RA value of
0.16, which however corresponded to an animal derived strain)
[23]. Because the Netherlands has been exceptionally successful in
reducing nosocomial spread of MRSA [23,24], RA values are
likely to be higher (and hence coexistence ranges broader) in most
other settings. The sensitivity on RA also implies that in regions
with better infection control in hospitals (and hence lower RA) one
would expect CA-MRSA to completely replace HA-MRSA and
hence also to cause most MRSA infections in hospitals.
Even though our model realistically includes several levels of
population structure, our analysis might still underestimate the
range over which CA-MRSA and HA-MRSA can coexist. First,
other types of heterogeneity might promote coexistence in a
similar way as the ones discussed here. Examples include spatial
heterogeneities like rural vs. urban areas, small vs. large hospitals
(which would impose different levels of stochastic effects and
thereby affect strain abundances [25]), the cycling of older patients
into long-term care facilities [26], or the highly variable length of
time individuals remain colonized [27]. We also neglected (due to
the absence of data) age- or department-structured antibiotic usage
rates in hospitals, though this could further promote coexistence.
Temporal heterogeneity, such as the seasonal use of antibiotics
might be an additional factor contributing to coexistence in
MRSA [28]. We have also broadly categorized the multitude of
different MRSA strains as either CA- or HA-MRSA. This
diversity could also contribute to coexistence, as different strains
may have different resistance phenotypes (It should be noted
however that explaining the coexistence of such individual strains
is an additional challenge). In addition to such heterogeneities,
coexistence might be facilitated by co-infection with different
strains [29,30], either through co-colonization of the nares [30] or
specialization of different strains to different anatomical sites. For
instance, CA-MRSA primarily causes infections of the skin,
whereas HA-MRSA infections are generally more invasive [2,14].
However, it is not clear to what extent different MRSA strains can
co-infect a host, and it has also been shown in a different context
that co-infection leads only under very specific conditions to
coexistence [15,16]. Moreover, other studies have shown that
Figure 5. The blue area indicates the parameter combinations for which HA-MRSA and CA-MRSA coexist in the treatment-
structured model. The red area indicates coexistence in the treatment- and age-structured model. Axes and parameter values are the same as in
Figure 3.
doi:10.1371/journal.ppat.1003134.g005
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Figure 6. A) The blue area indicates the parameter combinations for which HA-MRSA and CA-MRSA coexist in the basic model. The
red area indicates coexistence in the age-structured model. B) The blue area indicates the parameter combinations for which HA-MRSA and CA-MRSA
coexist in the treatment-structured model. The red area indicates co-existence in the treatment- and age-structured model. The x-axis corresponds to
the fitness disadvantage of HA-MRSA compared to CA-MRSA in the community in the absence of effective therapy. The y-axis corresponds to ratio
between the fitness costs of HA-MRSA in hospital and community.
doi:10.1371/journal.ppat.1003134.g006
Figure 7. Coexistence between HA-MRSA and CA-MRSA in the transient phase after the introduction of CA-MRSA into the HA-
MRSA-infected host population in the treatment- and age-structured model (corresponding to the red area in Figure 5). Colors
indicate which strains have frequencies .5% among the colonized patients in the hospital (HA-MRSA) and the community (CA-MRSA): Blue indicates
coexistence (i.e. both strains .5%), dark grey indicates HA-MRSA only, and light grey CA-MRSA only. The dashed orange line delimits the parameter
region in which HA-MRSA can invade MSSA (criterion for invasion: frequency of MRSA .5%, 50 years after its introduction; see Figure S2).
doi:10.1371/journal.ppat.1003134.g007
Coexistence of MRSA Strains
PLOS Pathogens | www.plospathogens.org 11 February 2013 | Volume 9 | Issue 2 | e1003134
colonization with MSSA can be protective from MRSA [31,32],
suggesting that competition may limit the extent of co-colonization
with different strains.
Even though our model can explain the coexistence between
HA-MRSA and CA-MRSA, we did not find any parameter
combination that supports coexistence at equilibrium between
more than two strains (HA-MRSA, CA-MRSA and MSSA). This
suggests that the system as described by our model corresponds to
only two ecological niches. This implies that the maintenance of
the diversity within HA-MRSA and CA-MRSA has to be
explained by mechanisms not included in our model (such as the
geographical and temporal variation mentioned above). More-
over, Figures 7, 8, and S3 also indicate that the system approaches
equilibrium only very slowly, such that a long transient mainte-
nance of this diversity is conceivable even if it would not persist in
an equilibrium state.
Our model also describes a static situation in which the
properties of the strains and the age structure do not change over
time. However, both demographic change in the human
population and evolutionary change of the MRSA strains are
likely to occur and their impact on coexistence between competing
strains is an interesting question for future studies. Demographic
change will most likely increase the proportion of old people in the
US and most western countries. In the context of our model this
means that selection will tend to favor hospital adapted strains, as
the hospitalization rates are considerably higher for the old age
classes. However, the direction of evolutionary change depends
very strongly on the physiological constraints underlying antibiotic
resistance. For instance, if CA-MRSA can increase its resistance
spectrum while maintaining a high transmissibility, it could
eventually out-compete HA-MRSA. If on the other hand a higher
fitness cost is the inevitable consequence of a broad resistance
spectrum, then such a replacement is unlikely to occur. Such
evolutionary changes may be particularly important given the very
long transient phases during which CA- and HA-MRSA can
coexist. These long transient phases provide the opportunity for
evolutionary adaptation of the inferior strain (by way of
compensatory mutations or extension of the resistance spectrum),
which could allow it to persist, even though coexistence is not
expected on the basis of the current pathogen fitness.
The classical ecological paradigm of niche overlap states that
two species can coexist if their resource usage differs sufficiently
[33]. The present study represents an application of those
concepts to the important public health question of whether
hospital- and community-associated strains of MRSA are
expected to coexist in the long-term. An eventual replacement
of HA-MRSA by CA-MRSA could cause important changes in
the epidemiology of S. aureus. CA-MRSA can more readily cause
infections in healthy individuals than HA-MRSA [18] and hence
symptomatic MRSA infections could extend to a broader class of
patients. CA-MRSA strains have also been associated with a
higher virulence and invasiveness than HA-MRSA strains [34], as
well as worse clinical outcomes [35,36]. This higher virulence and
invasiveness has been associated with an increased expression of
several cytolytic toxins (such as PVL). However, the exact
mechanisms underlying the higher virulence of CA-MRSA are
still uncertain [34]. An increase in virulence is also not universal,
as other studies have described better clinical outcomes associated
with CA-MRSA infections [37,38]. This may be because CA-
MRSA infections are largely associated with skin and soft-tissue
infections, which generally have favorable outcomes [38,39]. In
addition, CA-MRSA strains have a narrower resistance spectrum
which makes it easier to provide effective treatment. Overall,
while the empirical evidence is mixed, there does seem to be
some indication that CA-MRSA differs from HA-MRSA with
regards to virulence, the range of resistance, and transmissibility
Figure 8. Coexistence between MSSA, HA-MRSA and CA-MRSA in the transient phase after the introduction of CA-MRSA into the
HA-MRSA/MSSA-infected host population in the treatment- and age-structured model. Colors (see legend) indicate which strains have
frequencies .5% among the colonized patients in the hospital (HA-MRSA) and the community (MSSA/CA-MRSA).
doi:10.1371/journal.ppat.1003134.g008
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(see Table 1 in [18], and [34]). Accordingly, a replacement of
HA-MRSA with CA-MRSA in hospitals would entail a change in
these important properties of nosocomial MRSA infections.
More fundamentally, the transmission route of MRSA in
hospitals might change. The current view is that MRSA in
hospitals is mainly transmitted indirectly through short-term
contaminated health-care workers [40]. This dynamic could
change should the more invasive and more transmissible CA-
MRSA replace HA-MRSA in hospitals. Accordingly, prevention
efforts that focus currently on hand-hygiene among health-care
workers could lose their effectiveness in reducing the spread of
MRSA. Interestingly, our results suggest that a replacement of
HA-MRSA by CA-MRSA is especially likely in those locations in
which infection control in hospital is currently successful and
hence transmission rates in the hospital are low. However, our
results also indicate that due to the large heterogeneities
characterizing human populations, coexistence between hospital-
and community-associated strains of MRSA is overall a likely
outcome.
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